Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ER alpha negative MDA-MB-435 breast cancer model

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	391-391
Number of pages	1
Journal	Breast Cancer Research and Treatment
Volume	114
Issue number	2
DOIs	https://doi.org/10.1007/s10549-008-0016-3
Publication status	Published - Mar 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{3ae62bea7fdc4f3f87828801ee9c6072,

title = "Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ER alpha negative MDA-MB-435 breast cancer model",

keywords = "CELL LINES",

author = "Hadad, \{Sirwan M.\} and Virginia Appleyard and Thompson, \{Alastair M.\}",

year = "2009",

month = mar,

doi = "10.1007/s10549-008-0016-3",

language = "English",

volume = "114",

pages = "391--391",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ER alpha negative MDA-MB-435 breast cancer model

AU - Hadad, Sirwan M.

AU - Appleyard, Virginia

AU - Thompson, Alastair M.

PY - 2009/3

Y1 - 2009/3

KW - CELL LINES

U2 - 10.1007/s10549-008-0016-3

DO - 10.1007/s10549-008-0016-3

M3 - Letter

C2 - 18421577

SN - 0167-6806

VL - 114

SP - 391

EP - 391

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 2

ER -